Next report date
Report period
H1 2024
EPS estimate
0.37EUR
Revenue estimate
2.64 BEUR
0.280EUR
244.02 MEUR
5.15 BEUR
856.16 M
About SMITH & NEPHEW PLC ORD USD0.20
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Employees (FY)
19.55 K
Founded
1856
ISIN
GB0009223206
FIGI
BBG000C6PCB6
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
S&N Long.New CFO and medical shares becoming attractive?
Idea only. Don't trade based on my ramblings.
Only risk 1R on any trade.
SNN, Smith & Nephew ADR - Trailing Stop after a breakoutNYSE:SNN
This level had resisted six times.
At the breakout the sellers were clearly few at that point and this was really a must for my strategies.
Let's follow the trend in trailing stop.
SN. Trend continuation?Seems like the pullback is nearly finishing and a beautiful triangle is forming.
Smith and Nephew potential If short term trend line and 1445 can hold good potential bullish If not longer term Trend line could offer good R/R
Medical Tech Mar17With Intuitive, Stryker all up at all time highs i'm hunting for medical robotics companies to acquire.
Smith & Nephew looking for a move below 29 to get long
seekingalpha.com
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SMITH & NEPHEW PLC stocks are traded under the ticker NPW1.
SMITH & NEPHEW PLC is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
NPW1 earnings for the last quarter are 0.32 EUR per share, whereas the estimation was 0.34 EUR resulting in a −4.70% surprise. The estimated earnings for the next quarter are 0.44 EUR per share. See more details about SMITH & NEPHEW PLC earnings.
SMITH & NEPHEW PLC revenue for the last quarter amounts to 2.51 B EUR despite the estimated figure of 2.49 B EUR. In the next quarter revenue is expected to reach 2.54 B EUR.
Yes, you can track SMITH & NEPHEW PLC financials in yearly and quarterly reports right on TradingView.
NPW1 net income for the last quarter is 83.76 M EUR, while the quarter before that showed 162.31 M EUR of net income which accounts for −48.39% change. Track more SMITH & NEPHEW PLC financial stats to get the full picture.
SMITH & NEPHEW PLC dividend yield was 2.80% in 2023, and payout ratio reached 124.23%. The year before the numbers were 2.82% and 150.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NPW1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMITH & NEPHEW PLC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 19.55 K employees. See our rating of the largest employees — is SMITH & NEPHEW PLC on this list?
We've gathered analysts' opinions on SMITH & NEPHEW PLC future price: according to them, NPW1 price has a max estimate of 17.69 EUR and a min estimate of 12.51 EUR. Read a more detailed SMITH & NEPHEW PLC forecast: see what analysts think of SMITH & NEPHEW PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SMITH & NEPHEW PLC EBITDA is 1.34 B EUR, and current EBITDA margin is 26.38%. See more stats in SMITH & NEPHEW PLC financial statements.